## **Core Concept**
The management of hypertension in diabetic patients requires careful consideration of the antihypertensive agent's effects on glucose metabolism, kidney function, and cardiovascular risk. Diabetic patients often have multiple comorbidities, and the chosen antihypertensive agent should ideally have beneficial or neutral effects on these conditions.

## **Why the Correct Answer is Right**
The correct answer, **ACE inhibitors (or ARBs)**, is preferred in diabetic patients with hypertension because these drugs have a protective effect on the kidneys. They reduce intraglomerular pressure and proteinuria, slowing the progression of diabetic nephropathy. ACE inhibitors (e.g., lisinopril, enalapril) and ARBs (e.g., losartan, valsartan) also have a neutral effect on glucose and lipid metabolism, making them suitable for diabetic patients.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Beta-blockers can mask symptoms of hypoglycemia and may worsen insulin resistance, making them less ideal as a first-line treatment for hypertension in diabetic patients.
- **Option B:** Thiazide diuretics can lead to metabolic side effects such as hypokalemia, hyperglycemia, and hyperuricemia, which are undesirable in diabetic patients.
- **Option C:** Calcium channel blockers, while effective in lowering blood pressure, do not offer the same renal protective effects as ACE inhibitors or ARBs in diabetic patients.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that ACE inhibitors and ARBs are considered first-line antihypertensive agents in patients with diabetes due to their renoprotective effects. They can be used alone or in combination with other antihypertensive agents to achieve blood pressure goals.

## **Correct Answer:** . **ACE inhibitors or ARBs**